Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narendra Agrawal

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 12, 2021
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignanciesPreethi Jeyaraman, Narendra Agrawal, Rahul Bhargava, et al.
European Journal of Haematology|July 5, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high riskPallavi Mehta, Jyotsna Kapoor, Aakanksha Singh, et al.
Journal of Infection in Developing Countries|December 17, 2013
Cytomegalovirus reactivation following hematopoietic stem cell transplantationSanjeev Kumar Sharma, Suman Kumar, Narendra Agrawal, et al.
Frontiers in Oncology|October 19, 2023
Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar eraReena Nair, Gull Mohammad Bhat, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From IndiaNeha Yadav, Mukul Aggarwal, Pallavi Mehta, et al.
American Journal of Blood Research|July 29, 2021
Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing countrySumeet Mirgh, Archana Sharma, Mohammad Rizwan Mohammad Anwar Shaikh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or DeeperSumeet Mirgh, Jyotsna Kapoor, Niharika Bhatia, et al.
Hemoglobin|March 4, 2025
Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative StudyVarsha Mishra, Pratibha Singh Yadav, Reema Singh, et al.
Hemoglobin|September 5, 2024
ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term ExperienceReema Singh, Rohan Halder, Vinayak Hemant Gupta, et al.
Cureus|August 19, 2022
Clinical and Epidemiological Profile of Elderly Hodgkin's Lymphoma in IndiaManish Sharma, Pankaj Goyal, Rajesh Ranjan, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 12, 2021
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignanciesPreethi Jeyaraman, Narendra Agrawal, Rahul Bhargava, et al.
European Journal of Haematology|July 5, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high riskPallavi Mehta, Jyotsna Kapoor, Aakanksha Singh, et al.
Journal of Infection in Developing Countries|December 17, 2013
Cytomegalovirus reactivation following hematopoietic stem cell transplantationSanjeev Kumar Sharma, Suman Kumar, Narendra Agrawal, et al.
Frontiers in Oncology|October 19, 2023
Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar eraReena Nair, Gull Mohammad Bhat, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From IndiaNeha Yadav, Mukul Aggarwal, Pallavi Mehta, et al.
American Journal of Blood Research|July 29, 2021
Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing countrySumeet Mirgh, Archana Sharma, Mohammad Rizwan Mohammad Anwar Shaikh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or DeeperSumeet Mirgh, Jyotsna Kapoor, Niharika Bhatia, et al.
Hemoglobin|March 4, 2025
Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative StudyVarsha Mishra, Pratibha Singh Yadav, Reema Singh, et al.
Hemoglobin|September 5, 2024
ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term ExperienceReema Singh, Rohan Halder, Vinayak Hemant Gupta, et al.
Cureus|August 19, 2022
Clinical and Epidemiological Profile of Elderly Hodgkin's Lymphoma in IndiaManish Sharma, Pankaj Goyal, Rajesh Ranjan, et al.
Pageof 6